Quorum Review IRB will celebrate the launch of Q Consent as the new standard in electronic informed consent at DIA 2017 in booth #2212. Kinetiq, the consulting and technology division of Quorum, also will be featured in two sessions at next week’s DIA conference with topics that range from emerging trends to best practices in clinical research.

“As always, we look forward to presenting subject matter expertise on topics that positively impact the clinical research community,” said Quorum CEO Cami Gearhart. “Our mission at Quorum is to move research forward together, and our Q Consent tool will help researchers and sponsors move forward with a new standard in consenting. We invite DIA attendees to visit us, celebrate our launch, and find out why secure electronic informed consent is now easy and affordable.”

Breakout Sessions

Kinetiq Regulatory Attorney Aarthi B. Iyer will present regulatory insights in an informative session on postmarketing safety studies. Study sponsors and CROs will learn how to maximize the impact of postmarketing studies and achieve effective execution and compliance. This session takes place on Monday, June 19 at 11:00 a.m.

James Riddle, Vice President of Client Services for Kinetiq, will be featured in a breakout session, where he and representatives from HHS will discuss the new Common Rule and its impact on sponsors and CROs. This session is scheduled for Wednesday, June 21 at 2:00 p.m.

Celebrate the Q Consent Launch

Visit Quorum and Kinetiq in the exhibit hall on Monday, June 19 at 4:45 p.m. at booth 2212, where Quorum will host a champagne toast to celebrate the launch of a revolutionary eConsent solution: Q Consent.